Before you sell to, join or invest in Senti Biosciences, Inc.
MentionFox check on Senti Biosciences, Inc.: no red flags found in 3 sources (checked 6 November 2026). mentionfox.com/c/funding/senti-biosciences-inc-form-d-24000001
Check Senti Biosciences, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
Senti Biosciences, Inc. filed a Form D with the Securities and Exchange Commission on 2024-12-19.
Senti Biosciences, Inc. filed a Form D notice of an exempt securities offering with the SEC on December 19, 2024. Senti Biosciences, Inc. trades on Nasdaq as SNTI. The filing reports $37.60M sold. Its industry group is Biotechnology. It names Timothy Lu (Executive Officer, Director), Kanya Rajangam (Executive Officer), Brenda Cooperstone (Director) (SEC Form D, December 19, 2024).
In its own words: “Outsmarting Complex Diseases With More Intelligent Medicines.” (sentibio.com, checked November 2, 2026)
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Senti Biosciences, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2024-12-19 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Senti Biosciences, Inc.
Free to see. No signup.
More on the people and the money behind Senti Biosciences, Inc., from the filings we hold.
Leerink Partners LLC received sales compensation on this raise and on 15 other raises we hold, nearest in date first:
Get an email when Senti Biosciences, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Senti Biosciences, Inc. raises, hires or launches. No email unless you switch it on.
Watch Senti Biosciences, Inc. →Get the full cited report on Senti Biosciences, Inc.
What the filing shows about Senti Biosciences, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Senti Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Senti Biosciences, Inc.'s address as 2 Corporate Drive, First Floor, South San Francisco, CA 94080.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Senti Biosciences Holdings, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Senti Biosciences, Inc. See pricing
Senti Biosciences, Inc. is a registered filer with the SEC (CIK 1854270) and has filed since 2024-12-19. 2 filings are on record, the latest on 2026-06-04.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Senti Biosciences, Inc.'s Form D of 2024-12-19 names Timothy Lu, Kanya Rajangam, Brenda Cooperstone and 5 more as its officers, directors or promoters.
Its new offerings report $47.60M sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 763 filings in Biotechnology, totalled by week.
Timothy Lu is named as Executive Officer and Director on the Form D that Senti Biosciences, Inc. filed with the SEC on 19 December 2024, one of 8 people that filing names.
Kanya Rajangam is named as Executive Officer on the Form D that Senti Biosciences, Inc. filed with the SEC on 19 December 2024, one of 8 people that filing names.
Brenda Cooperstone is named as Director on the Form D that Senti Biosciences, Inc. filed with the SEC on 19 December 2024, one of 8 people that filing names.
Edward Mathers is named as Director on the Form D that Senti Biosciences, Inc. filed with the SEC on 19 December 2024, one of 8 people that filing names.
James Collins is named as Director on the Form D that Senti Biosciences, Inc. filed with the SEC on 19 December 2024, one of 8 people that filing names.
Fran Schulz is named as Director on the Form D that Senti Biosciences, Inc. filed with the SEC on 19 December 2024, one of 8 people that filing names.
Donald Tang is named as Director on the Form D that Senti Biosciences, Inc. filed with the SEC on 19 December 2024, one of 8 people that filing names.
Yvonne Li is named as Executive Officer on the Form D that Senti Biosciences, Inc. filed with the SEC on 19 December 2024, one of 8 people that filing names.
8 people named on the filing — 3 holding an executive role and 5 as directors only.
Named as of the 2024-12-19 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Senti Biosciences, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Senti Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Senti Biosciences, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Senti Biosciences, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Senti Biosciences, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Senti Biosciences, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in San Francisco Bay Area
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/senti-biosciences-inc-form-d-24000001